Drug Profile
DTwP-Hb-Hib pentavalent vaccine - Indian Immunologicals
Alternative Names: HBI Pentavalent vaccineLatest Information Update: 18 Feb 2022
Price :
$50
*
At a glance
- Originator Indian Immunologicals
- Class Haemophilus vaccines; Hepatitis B vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 18 Feb 2022 No development reported - Phase-III for Diphtheria (Prevention) in India (IM) (Indian Immunologicals pipeline, February 2022)
- 18 Feb 2022 No development reported - Phase-III for Haemophilus infections (Prevention) in India (IM) (Indian Immunologicals pipeline, February 2022)
- 18 Feb 2022 No development reported - Phase-III for Hepatitis B (Prevention) in India (IM) (Indian Immunologicals pipeline, February 2022)